Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

Background The aim of this study was to investigate whether bioactive adrenomedullin (bio-ADM) and interleukin-6 (IL-6) are related to acute kidney injury (AKI) and severe illness in COVID-19 patients. Methods 153 patients with COVID-19 admitted to the emergency department (ED) were included. Blood...

Full description

Bibliographic Details
Main Authors: Simon B. Leininger, Stephan T. Staudner, Manuel J. Vogel, Julian Mustroph, Ute Hubauer, Stefan Wallner, Petra Lehn, Ralph Burkhardt, Christine Meindl, Frank Hanses, Markus Zimmermann, Lars S. Maier, Julian Hupf, Carsten G. Jungbauer
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Nephrology
Subjects:
COVID-19
SARS-CoV-2
Adrenomedullin
Interleukin-6
Acute Kidney Injury
Online Access:https://doi.org/10.1186/s12882-024-03486-1

Internet

https://doi.org/10.1186/s12882-024-03486-1

Similar Items